102.02
0.00
(0.00%)
As of April 7 at 9:30:08 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 17 | 17 | 21 | 20 |
Avg. Estimate | 19.78B | 20.73B | 84.27B | 89.27B |
Low Estimate | 19.26B | 20.23B | 83.31B | 87.64B |
High Estimate | 20.19B | 21.37B | 85.58B | 92.71B |
Year Ago Sales | 19.3B | 19.79B | 80.74B | 84.27B |
Sales Growth (year/est) | 2.46% | 4.77% | 4.38% | 5.93% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
5URD.XC | -- | -- | -- | -- |
S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
Maintains | Wells Fargo: Overweight to Overweight | 4/8/2025 |
Upgrade | Baird: Neutral to Outperform | 3/19/2025 |
Upgrade | UBS: Neutral to Buy | 2/24/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 1/30/2025 |
Maintains | B of A Securities: Buy to Buy | 1/30/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 1/29/2025 |